Eurazeo(0HZC)
EUR --+0.00%
Reward58Moderate
Risk31Moderate
📊50%Data
4.4% dividend yield · Revenue down 39% YoY
0HZC
+0.0 · +0.00%
EUR · LSE
Eurazeo |
Dividend King
Market Cap:5.46Bn
ℹ️
Reward Rating
58
Moderate
Top 50% (model universe)
50% data coverage
ℹ️
Risk Rating
31
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0HZC to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Eurazeo?

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments.

0HZC · Verdict

Solid reward · moderate risk

0HZC stands out on cash flow and balance sheet, but watch the profitability signal.

Based on 75% data coverage

0HZC · Verdict

What’s working & what to watch

Strengths 3

  • Cash flow80/100

    Top decile vs peers

  • Balance sheet75/100

    Current ratio 1.05

  • Growth70/100

    Above average

Watchouts 1

  • Profitability42/100

    -6% return on equity

Model-based scoring. For information only — not financial advice.

What is Eurazeo?

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. The company is listed on the LSE in UK, with a market capitalisation of 5.46B.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (58)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap5.46B
P/E RatioN/A
Dividend Yield4.44%
52 Week High67.5876
52 Week Low37.3
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares OutstandingN/A
No. of Employees578
IndustryN/A
ExchangeLSE
Beta1.139
CurrencyEUR